MONTE ROSA THERAPEUTICS INC (GLUE) Institutional Shareholders
MONTE ROSA THERAPEUTICS INC (GLUE) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $2.22B in GLUE holdings during the latest filing period.
Price T Rowe Associates Inc is currently the largest disclosed institutional shareholder of GLUE tracked by InsiderSet, reporting ownership valued at approximately $214.44M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $112.09M, representing an estimated loss of -47.73% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 57% of the total disclosed GLUE value among the investors covered in this analysis. Major shareholders include Price T Rowe Associates Inc, Nea Management Company, Llc, Blackrock, Inc., and several other long-term asset managers with concentrated positions in MONTE ROSA THERAPEUTICS INC (GLUE).
This page ranks the largest institutional GLUE shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
187
Total Reported Value
$2.22B
Largest Holder
Price T Rowe Associates Inc
Largest Position
$214.44M
Insider Transactions (90d)
15
Latest Filing Quarter
Q2 2026
New Institutional Positions
64
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Price T Rowe Associates Inc | 0.02% | 8,861,171 | $214,442,000 | $112,093,813 | -$102,348,187 | -47.73% | |
| Nea Management Company, Llc | 11.72% | 7,692,298 | $186,153,612 | $97,307,570 | -$88,846,042 | -47.73% | |
| Blackrock, Inc. | 0.00% | 6,843,087 | $165,602,706 | $86,565,051 | -$79,037,655 | -47.73% | |
| Tcg Crossover Management, Llc | 2.69% | 4,622,151 | $111,856,054 | $58,470,210 | -$53,385,844 | -47.73% | |
| Vestal Point Capital, Lp | 2.60% | 4,600,000 | $111,320,000 | $58,190,000 | -$53,130,000 | -47.73% | |
| Bvf Inc/Il | 2.76% | 4,460,886 | $107,953,441 | $56,430,208 | -$51,523,233 | -47.73% | |
| Baker Bros. Advisors Lp | 0.53% | 4,345,736 | $105,166,811 | $54,973,560 | -$50,193,251 | -47.73% | |
| State Street Corp | 0.00% | 3,731,416 | $90,300,267 | $47,202,412 | -$43,097,855 | -47.73% | |
| Suvretta Capital Management, Llc | 1.81% | 3,549,539 | $85,898,844 | $44,901,668 | -$40,997,176 | -47.73% | |
| Vanguard Capital Management Llc | 0.00% | 3,412,927 | $82,592,833 | $43,173,527 | -$39,419,306 | -47.73% | |
| Versant Venture Management, Llc | 47.34% | 3,180,780 | $76,974,876 | $40,236,867 | -$36,738,009 | -47.73% | |
| Braidwell Lp | 2.19% | 2,451,562 | $59,327,800 | $31,012,259 | -$28,315,541 | -47.73% | |
| Geode Capital Management, Llc | 0.00% | 1,864,113 | $45,121,645 | $23,581,029 | -$21,540,616 | -47.74% | |
| American Century Companies Inc | 0.02% | 1,622,846 | $39,272,873 | $20,529,002 | -$18,743,871 | -47.73% | |
| Marshall Wace, Llp | 0.03% | 1,593,600 | $38,565,119 | $20,159,040 | -$18,406,079 | -47.73% | |
| Aisling Capital Management Lp | 7.98% | 1,555,664 | $37,647,069 | $19,679,150 | -$17,967,919 | -47.73% | |
| Bellevue Group Ag | 0.61% | 1,190,000 | $28,798,000 | $15,053,500 | -$13,744,500 | -47.73% | |
| Dimensional Fund Advisors Lp | 0.01% | 1,177,488 | $28,493,337 | $14,895,223 | -$13,598,114 | -47.72% | |
| Mpm Bioimpact Llc | 1.71% | 1,161,081 | $28,098,160 | $14,687,675 | -$13,410,485 | -47.73% | |
| Silverarc Capital Management, Llc | 2.98% | 1,108,295 | $26,820,739 | $14,019,932 | -$12,800,807 | -47.73% | |
| Frazier Life Sciences Management, L.P. | 0.53% | 1,000,000 | $24,200,000 | $12,650,000 | -$11,550,000 | -47.73% | |
| Goldman Sachs Group Inc | 0.00% | 998,253 | $24,157,723 | $12,627,900 | -$11,529,823 | -47.73% | |
| Woodline Partners Lp | 0.07% | 962,884 | $23,301,793 | $12,180,483 | -$11,121,310 | -47.73% | |
| Fmr Llc | 0.00% | 934,414 | $22,612,829 | $11,820,337 | -$10,792,492 | -47.73% | |
| Vanguard Portfolio Management Llc | 0.00% | 791,932 | $19,164,754 | $10,017,940 | -$9,146,814 | -47.73% | |
| Morgan Stanley | 0.00% | 789,545 | $19,106,990 | $9,987,744 | -$9,119,246 | -47.73% | |
| Nextech Invest, Ltd. | 0.87% | 761,153 | $18,419,903 | $9,628,585 | -$8,791,318 | -47.73% | |
| Opaleye Management Inc. | 1.63% | 745,000 | $18,029,000 | $9,424,250 | -$8,604,750 | -47.73% | |
| Northern Trust Corp | 0.00% | 652,087 | $15,780,505 | $8,248,901 | -$7,531,604 | -47.73% | |
| Nantahala Capital Management, Llc | 0.95% | 651,993 | $15,778,231 | $8,247,711 | -$7,530,520 | -47.73% | |
| First Trust Advisors Lp | 0.01% | 647,796 | $15,676,663 | $8,194,619 | -$7,482,044 | -47.73% | |
| Charles Schwab Investment Management Inc | 0.00% | 616,310 | $14,914,702 | $7,796,322 | -$7,118,381 | -47.73% | |
| Boone Capital Management Llc | 3.48% | 615,287 | $14,889,945 | $7,783,381 | -$7,106,564 | -47.73% | |
| Bridgeway Capital Management, Llc | 0.24% | 552,566 | $13,372,097 | $6,989,960 | -$6,382,137 | -47.73% | |
| Aqr Capital Management Llc | 0.00% | 520,648 | $12,599,682 | $6,586,197 | -$6,013,485 | -47.73% | |
| Vanguard Fiduciary Trust Co | 0.00% | 505,500 | $12,233,100 | $6,394,575 | -$5,838,525 | -47.73% | |
| Parkwood Llc | 0.88% | 505,000 | $12,221,000 | $6,388,250 | -$5,832,750 | -47.73% | |
| Janus Henderson Group Plc | 0.01% | 685,926 | $11,293,772 | $8,676,964 | -$2,616,808 | -23.17% | |
| Adage Capital Partners Gp, L.L.C. | 0.02% | 450,000 | $10,890,000 | $5,692,500 | -$5,197,500 | -47.73% | |
| Kennedy Capital Management Llc | 0.17% | 405,529 | $9,813,802 | $5,129,942 | -$4,683,860 | -47.73% | |
| Ameriprise Financial Inc | 0.00% | 383,335 | $9,276,708 | $4,849,188 | -$4,427,520 | -47.73% | |
| Alphabet Inc. | 0.01% | 372,474 | $9,013,871 | $4,711,796 | -$4,302,075 | -47.73% | |
| Fisher Asset Management, Llc | 0.00% | 363,520 | $8,797,182 | $4,598,528 | -$4,198,654 | -47.73% | |
| Allspring Global Investments Holdings, Llc | 0.01% | 352,857 | $8,539,139 | $4,463,641 | -$4,075,498 | -47.73% | |
| Empowered Funds, Llc | 0.04% | 329,266 | $7,968,237 | $4,165,215 | -$3,803,022 | -47.73% | |
| Duquesne Family Office Llc | Stanley Druckenmiller | 0.17% | 297,600 | $7,202,000 | $3,764,640 | -$3,437,360 | -47.73% |
| Td Asset Management Inc | 0.01% | 285,936 | $6,919,651 | $3,617,090 | -$3,302,561 | -47.73% | |
| Bank Of America Corp | 0.00% | 254,561 | $6,160,376 | $3,220,197 | -$2,940,179 | -47.73% | |
| Bank Of New York Mellon Corp | 0.00% | 222,521 | $5,385,007 | $2,814,891 | -$2,570,116 | -47.73% | |
| Longaeva Partners L.P. | 0.15% | 216,792 | $5,246,366 | $2,742,419 | -$2,503,947 | -47.73% |
Frequently asked questions about GLUE
Who owns the most GLUE stock?
The largest holders of GLUE are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for MONTE ROSA THERAPEUTICS INC (GLUE).
Is GLUE widely held by superinvestors?
Many widely followed stocks like GLUE appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly GLUE is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.